STOCK TITAN

[Form 4] Eastman Chemical Company Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Insider purchases and deferred-compensation award reported for Eastman Chemical (EMN)

Brian Travis Smith, an executive (EVP, AFP, Mfg., WWEC & HSE) reported acquiring 1,750 shares of Eastman common stock at a price of $68.34 per share, bringing his direct beneficial ownership to 16,732 shares. Separately, he was credited with 2,200 phantom stock units under the company Executive Deferred Compensation Plan; those units have a value tied to the company common stock at $68.18 per share and are payable in cash, with the report showing 2,208 underlying shares equivalent following the award. The phantom units are subject to plan terms including limited acceleration and withdrawal provisions and are payable after termination of employment. The filing reflects routine insider equity purchases and a deferred-compensation award that links pay to the issuer stock value.

Acquisti da parte di insider e premio in compenso differito segnalati per Eastman Chemical (EMN)

Brian Travis Smith, dirigente (EVP, AFP, Mfg., WWEC & HSE), ha dichiarato di aver acquisito 1.750 azioni ordinarie di Eastman al prezzo di $68,34 ciascuna, portando la sua partecipazione diretta a 16.732 azioni. Separatamente, gli sono stati accreditati 2.200 unità di azioni fantasma nell'ambito del Piano Esecutivo di Compenso Differito della società; il valore di tali unità è collegato all'azione ordinaria della società a $68,18 per azione e saranno corrisposte in contanti, con la segnalazione che l'equivalente post-premio corrisponde a 2.208 azioni sottostanti. Le unità fantasma sono soggette ai termini del piano, inclusi limiti su accelerazione e prelievo, e vengono pagate dopo la cessazione dell'impiego. La comunicazione riflette acquisti azionari di routine da parte di un insider e un premio in compenso differito che lega la retribuzione al valore del titolo dell'emittente.

Compras de insider y premio de compensación diferida reportados para Eastman Chemical (EMN)

Brian Travis Smith, ejecutivo (EVP, AFP, Mfg., WWEC & HSE), informó la adquisición de 1.750 acciones ordinarias de Eastman a $68,34 por acción, elevando su propiedad directa a 16.732 acciones. Por separado, se le acreditaron 2.200 unidades de acciones fantasma bajo el Plan Ejecutivo de Compensación Diferida de la compañía; esas unidades tienen un valor vinculado a la acción ordinaria de la compañía de $68,18 por acción y se pagarán en efectivo, mostrando el informe que equivalen a 2.208 acciones subyacentes tras la concesión. Las unidades fantasma están sujetas a los términos del plan, incluidos límites en la aceleración y disposiciones de retiro, y se pagan después de la terminación del empleo. La presentación refleja compras de acciones rutinarias por parte de un insider y un premio de compensación diferida que vincula la remuneración al valor de las acciones del emisor.

Eastman Chemical(EMN)의 내부자 매수와 이연 보상 수령 보고

임원(사장직 부사장 EVP, AFP, 제조, WWEC & HSE)인 브라이언 트래비스 스미스는 자사 보통주 1,750주를 주당 $68.34에 취득해 본인 직접 소유 지분이 16,732주가 되었다고 보고했습니다. 별도로, 회사의 임원 이연 보상 계획에 따라 2,200개의 팬텀 스톡 유닛이 크레딧되었으며, 이 유닛의 가치는 주당 $68.18로 회사 보통주에 연동되고 현금으로 지급됩니다. 보고서에는 수여 후 2,208주의 실질적 기초 주식에 해당한다고 표시되어 있습니다. 팬텀 유닛은 가속화 제한 및 인출 규정 등 계획의 조건이 적용되며 고용 종료 후에 지급됩니다. 이 신고는 내부자의 통상적인 주식 매수와 보상 금액을 발행사 주가와 연동하는 이연 보상 수령을 반영합니다.

Achats par des initiés et attribution de rémunération différée signalés pour Eastman Chemical (EMN)

Brian Travis Smith, cadre (EVP, AFP, Mfg., WWEC & HSE), a déclaré avoir acquis 1 750 actions ordinaires d'Eastman au prix de 68,34 $ par action, portant sa détention directe à 16 732 actions. Par ailleurs, 2 200 unités d'actions fictives (phantom stock units) lui ont été créditées dans le cadre du Executive Deferred Compensation Plan de la société ; la valeur de ces unités est liée à l'action ordinaire de la société à 68,18 $ par action et sera réglée en espèces, le rapport indiquant qu'elles correspondent à 2 208 actions sous-jacentes après attribution. Les unités fictives sont soumises aux conditions du plan, notamment des limites en matière d'accélération et de retrait, et sont payables après la fin de l'emploi. Le dossier reflète des achats d'actions courants par un initié et une attribution de rémunération différée liant la paye à la valeur de l'action de l'émetteur.

Insider-Käufe und Zuteilung von aufgeschobener Vergütung bei Eastman Chemical (EMN) gemeldet

Brian Travis Smith, ein leitender Angestellter (EVP, AFP, Mfg., WWEC & HSE), meldete den Erwerb von 1.750 Eastman-Stammaktien zu je $68,34, wodurch sein direktes wirtschaftliches Eigentum auf 16.732 Aktien anstieg. Separat wurden ihm 2.200 phantom stock units im Rahmen des Executive Deferred Compensation Plan des Unternehmens gutgeschrieben; der Wert dieser Einheiten ist an die Stammaktie des Unternehmens bei $68,18 je Aktie gekoppelt und wird in bar ausgezahlt. Der Bericht zeigt, dass dies nach der Zuteilung 2.208 zugrundeliegenden Aktien entspricht. Die Phantom-Einheiten unterliegen den Planbedingungen, einschließlich begrenzter Beschleunigungs- und Auszahlungsregeln, und werden nach Beendigung des Arbeitsverhältnisses ausgezahlt. Die Meldung spiegelt routinemäßige Insider-Aktienkäufe und eine aufgeschobene Vergütungszuteilung wider, die die Vergütung an den Kurs der Emittentenaktie koppelt.

Positive
  • Insider open-market purchase of 1,750 shares at $68.34 demonstrates executive buying of company stock
  • Deferred-compensation award uses phantom stock units tied to common stock value, aligning executive pay with shareholder outcomes
  • Phantom units are cash-settled, so the award does not dilute outstanding shares
Negative
  • None.

Insights

TL;DR: Routine insider purchase and deferred-compensation grant, aligns executive pay with shareholder value.

The reported open-market acquisition of 1,750 shares by an executive officer and the grant of phantom stock units are standard governance outcomes that generally signal alignment of management incentives with shareholders. The phantom units are cash-settled and subject to plan acceleration and withdrawal rules, so they do not dilute share count but do tie compensation value to share price movements. This filing is informational and not unusual for senior executives.

TL;DR: Small-scale insider purchase; transaction size is modest relative to typical market cap impact.

The purchase of 1,750 shares at the reported price increases the officer s direct holdings to 16,732 shares. While insider buying can be a positive signal, the absolute size here is unlikely to materially affect capital structure or market perceptions absent larger, corroborating transactions. The phantom units represent deferred cash compensation linked to share value rather than issuance of equity, limiting immediate market impact.

Acquisti da parte di insider e premio in compenso differito segnalati per Eastman Chemical (EMN)

Brian Travis Smith, dirigente (EVP, AFP, Mfg., WWEC & HSE), ha dichiarato di aver acquisito 1.750 azioni ordinarie di Eastman al prezzo di $68,34 ciascuna, portando la sua partecipazione diretta a 16.732 azioni. Separatamente, gli sono stati accreditati 2.200 unità di azioni fantasma nell'ambito del Piano Esecutivo di Compenso Differito della società; il valore di tali unità è collegato all'azione ordinaria della società a $68,18 per azione e saranno corrisposte in contanti, con la segnalazione che l'equivalente post-premio corrisponde a 2.208 azioni sottostanti. Le unità fantasma sono soggette ai termini del piano, inclusi limiti su accelerazione e prelievo, e vengono pagate dopo la cessazione dell'impiego. La comunicazione riflette acquisti azionari di routine da parte di un insider e un premio in compenso differito che lega la retribuzione al valore del titolo dell'emittente.

Compras de insider y premio de compensación diferida reportados para Eastman Chemical (EMN)

Brian Travis Smith, ejecutivo (EVP, AFP, Mfg., WWEC & HSE), informó la adquisición de 1.750 acciones ordinarias de Eastman a $68,34 por acción, elevando su propiedad directa a 16.732 acciones. Por separado, se le acreditaron 2.200 unidades de acciones fantasma bajo el Plan Ejecutivo de Compensación Diferida de la compañía; esas unidades tienen un valor vinculado a la acción ordinaria de la compañía de $68,18 por acción y se pagarán en efectivo, mostrando el informe que equivalen a 2.208 acciones subyacentes tras la concesión. Las unidades fantasma están sujetas a los términos del plan, incluidos límites en la aceleración y disposiciones de retiro, y se pagan después de la terminación del empleo. La presentación refleja compras de acciones rutinarias por parte de un insider y un premio de compensación diferida que vincula la remuneración al valor de las acciones del emisor.

Eastman Chemical(EMN)의 내부자 매수와 이연 보상 수령 보고

임원(사장직 부사장 EVP, AFP, 제조, WWEC & HSE)인 브라이언 트래비스 스미스는 자사 보통주 1,750주를 주당 $68.34에 취득해 본인 직접 소유 지분이 16,732주가 되었다고 보고했습니다. 별도로, 회사의 임원 이연 보상 계획에 따라 2,200개의 팬텀 스톡 유닛이 크레딧되었으며, 이 유닛의 가치는 주당 $68.18로 회사 보통주에 연동되고 현금으로 지급됩니다. 보고서에는 수여 후 2,208주의 실질적 기초 주식에 해당한다고 표시되어 있습니다. 팬텀 유닛은 가속화 제한 및 인출 규정 등 계획의 조건이 적용되며 고용 종료 후에 지급됩니다. 이 신고는 내부자의 통상적인 주식 매수와 보상 금액을 발행사 주가와 연동하는 이연 보상 수령을 반영합니다.

Achats par des initiés et attribution de rémunération différée signalés pour Eastman Chemical (EMN)

Brian Travis Smith, cadre (EVP, AFP, Mfg., WWEC & HSE), a déclaré avoir acquis 1 750 actions ordinaires d'Eastman au prix de 68,34 $ par action, portant sa détention directe à 16 732 actions. Par ailleurs, 2 200 unités d'actions fictives (phantom stock units) lui ont été créditées dans le cadre du Executive Deferred Compensation Plan de la société ; la valeur de ces unités est liée à l'action ordinaire de la société à 68,18 $ par action et sera réglée en espèces, le rapport indiquant qu'elles correspondent à 2 208 actions sous-jacentes après attribution. Les unités fictives sont soumises aux conditions du plan, notamment des limites en matière d'accélération et de retrait, et sont payables après la fin de l'emploi. Le dossier reflète des achats d'actions courants par un initié et une attribution de rémunération différée liant la paye à la valeur de l'action de l'émetteur.

Insider-Käufe und Zuteilung von aufgeschobener Vergütung bei Eastman Chemical (EMN) gemeldet

Brian Travis Smith, ein leitender Angestellter (EVP, AFP, Mfg., WWEC & HSE), meldete den Erwerb von 1.750 Eastman-Stammaktien zu je $68,34, wodurch sein direktes wirtschaftliches Eigentum auf 16.732 Aktien anstieg. Separat wurden ihm 2.200 phantom stock units im Rahmen des Executive Deferred Compensation Plan des Unternehmens gutgeschrieben; der Wert dieser Einheiten ist an die Stammaktie des Unternehmens bei $68,18 je Aktie gekoppelt und wird in bar ausgezahlt. Der Bericht zeigt, dass dies nach der Zuteilung 2.208 zugrundeliegenden Aktien entspricht. Die Phantom-Einheiten unterliegen den Planbedingungen, einschließlich begrenzter Beschleunigungs- und Auszahlungsregeln, und werden nach Beendigung des Arbeitsverhältnisses ausgezahlt. Die Meldung spiegelt routinemäßige Insider-Aktienkäufe und eine aufgeschobene Vergütungszuteilung wider, die die Vergütung an den Kurs der Emittentenaktie koppelt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SMITH BRIAN TRAVIS

(Last) (First) (Middle)
200 S. WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, AFP, Mfg., WWEC & HSE
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/27/2025 P 1,750 A $68.34 16,732 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units (1) 08/28/2025 J 2,200 (1) (1) Common Stock 2,200 $68.18 2,208 D
Explanation of Responses:
1. Phantom Stock Units acquired under the Executive Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash and subject to certain acceleration and early withdrawal provisions, after termination of employment. Additional Remarks
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Brian Travis Smith 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for Eastman Chemical (EMN)?

An executive officer acquired 1,750 common shares at $68.34 per share and was credited with 2,200 phantom stock units valued at $68.18 per unit.

Who filed the Form 4 for EMN and what is their role?

The filing reports transactions by Brian Travis Smith, identified as EVP, AFP, Manufacturing, WWEC & HSE, filing as a reporting person.

How many shares does the reporting person own after the reported purchase?

Following the reported acquisition, the filing shows direct beneficial ownership of 16,732 common shares.

What are the phantom stock units reported in the filing?

The filing reports 2,200 phantom stock units under the Executive Deferred Compensation Plan; they are cash-settled, tied to common stock value, and payable after termination under plan terms.

Do the phantom units dilute Eastman Chemical's outstanding shares?

No; the phantom stock units are payable in cash and therefore do not represent newly issued shares or cause dilution according to the filing.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

7.90B
113.84M
0.76%
92%
2.32%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT